ABSTRACT
BACKGROUND Intracerebral hemorrhage (ICH) has a high mortality rate, and even if patients survive, they are likely to have severe disability. Body mass index (BMI) is associated with ICH risk, and extremely low and high BMIs are associated with the site of ICH, which affects functional decline. However, few reports exist on ICH-related functional decline and BMI. This study aimed to clarify the relationship between BMI and stroke-related disability of patients with ICH.
METHODS Patients with ICH registered in the Japanese Registry Of All Cardiac and Vascular Diseases Diagnosis Procedure Combination (JROAD-DPC) database from April 2016 to March 2020 were included. BMI was defined according to the World Health Organization Asia-Pacific classification. Functional disability was assessed using the modified Rankin Scale (mRS). ICH-related functional decline was defined as an increase in mRS score at discharge compared with that of the pre-stroke assessment.
RESULTS This study included 155,211 patients with ICH whose median age was 72.0 years and mean BMI was 22.3 kg/m2. The ratio of patients with ICH who experience functional decline was 74.9%. The spline curve between BMI and ICH-related functional decline was U-shaped, revealing that the Normal to Obese I BMI groups (BMI: 22.2–30.4 kg/m2) exhibited reduced odds ratios for ICH-related functional decline. Hospitalization cost and BMI showed similar U-shaped patterns, with a BMI of 25.0 kg/m2 as the lowest point, regardless of age group.
CONCLUSION In patients with ICH, those with both extremely low and high BMIs were more likely to experience functional decline after ICH onset, which resulted in increased hospitalization costs. To reduce ICH-related functional decline, patients should be managed at a normal to slightly obese BMI.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Because the present study was a retrospective cohort study with the J-ROAD DPC database.
Funding Statement
This work was supported by grants from the Japanese Circulation Society and JSPS KAKENHI [Grant Numbers JP22K11392 and JP22K19708].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
the Kobe University Institutional Review Board (Approval No. B210052)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Deidentified participant data in the JROAD-DPC study will not be shared.
Non-standard Abbreviations and Acronyms
- ADL
- activities of daily living
- BMI
- body mass index
- ICD-10
- International Statistical Classification of Diseases and Related Health Problems 10th Revision
- ICH
- intracerebral hemorrhage
- JROAD-DPC
- Japanese Registry Of All Cardiac and Vascular Diseases Diagnosis Procedure Combination
- mRS
- modified Rankin Scale
- UTI
- urinary tract infection
- WHO
- World Health Organization
